Migraine drug gets a breath of fresh air: inhaler version tested
Knowledge-focused
Completed
This early-stage study tested a new inhaled powder form of the migraine drug dihydroergotamine (DHE) in 44 healthy adults. Researchers compared how the body absorbs the drug when given as an inhaled powder, an injection, or a nasal spray. The goal was to measure safety and how we…
Phase: PHASE1 • Sponsor: Aspeya Switzerland SA • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC